MS
Morgan Stanley
MS has the edge over PEBO overall, supported by stronger modeled upside and stronger fundamentals.
PEBO
Peoples Bancorp Inc.
PEBO trails on the overall score without a compensating advantage in the available component scores.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
PEBO Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| N/A | |
| N/A |
PEBO's profitability is currently strong, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like PEBO.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS's PE is in its fair range at 15x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
PEBO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8.3x | $28.05 | -27% |
| Forward | 9.8x | $38.27 | — |
| Fair | 11x | $36.08 | -5.7% |
| Current | 11x | $38.27 | — |
| Expensive | 13x | $44.53 | +16% |
Historical ranges are pointers, not guarantees.
PEBO has the edge over MS in the historical PE scenario, which offers more potential upside but is not a forecast.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
MS has the edge over PEBO on the outlook, with more favorable profitability expectations.
PEBO Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Strong growth | |
| Strongly weakening | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for PEBO, but weaker profitability.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS has the edge over PEBO on earnings, with more consistent year-over-year improvement.
PEBO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.89 | +15% |
| Q3 2026 | $3.39 | +19% |
| Q2 2026 | $3.31 | +13% |
| Q1 2026 | $3.12 | -1% |
| Q4 2025 | $2.99 | -9.7% |
| Q3 2025 | $2.86 | -19% |
| Q2 2025 | $2.92 | -17% |
| Q1 2025 | $3.15 | -5.7% |
| Q4 2024 | $3.31 | -3.8% |
PEBO earned $3.39 per share over the past year, up 19% from the year before.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS has the edge over PEBO on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS's operating margin was 32% last quarter, down 1.2 points from the same quarter a year ago.
PEBO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $119.5M | +3.7% |
| Q2 2026 | $113.1M | -1.2% |
| Q1 2026 | $118.7M | +5.6% |
| Q4 2025 | $117.3M | +5.1% |
| Q3 2025 | $115.2M | +1.3% |
| Q2 2025 | $114.5M | +3.8% |
| Q1 2025 | $112.4M | -0.1% |
| Q4 2024 | $111.6M | -0.8% |
PEBO's revenue grew through 2024 and has held roughly level since: $119M last quarter, up 3.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 35% | +1.6 points |
| Q2 2026 | 32% | +7.5 points |
| Q1 2026 | 31% | +3.5 points |
| Q4 2025 | 32% | +1.1 points |
| Q3 2025 | 33% | -3 points |
| Q2 2025 | 24% | -8.5 points |
| Q1 2025 | 28% | -5.7 points |
| Q4 2024 | 31% | -7.5 points |
PEBO has the edge over MS on profitability, with a higher operating margin.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS's free cash flow was −$58.3B over the past year, against −$3.7B the year before. Free cash flow isn't a meaningful measure for financial services companies like MS.
PEBO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $47.1M | +270% |
| Q2 2026 | $55.2M | +12% |
| Q1 2026 | $33.3M | +5.6% |
| Q4 2025 | $35.2M | -11% |
| Q3 2025 | $12.7M | -62% |
| Q2 2025 | $49.2M | +63% |
| Q1 2025 | $31.5M | -4.9% |
| Q4 2024 | $39.8M | +43% |
PEBO has the edge over MS on cash generation, producing positive trailing cash flow while its opponent burns cash.
MS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -3M shares |
| 1 year | -1.5% | -24M shares |
| 3 years | -4.7% | -77M shares |
| 5 years | -14% | -246M shares |
| Available history | -4.5% | -74M shares |
MS has the edge over PEBO on shareholder dilution, with a more favorable share count trend.
PEBO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +95.9K shares |
| 1 year | +0.7% | +264K shares |
| 3 years | +1.7% | +601K shares |
| 5 years | +83% | +16.2M shares |
| Available history | +73% | +15.1M shares |
PEBO has 36M diluted shares, up 0.7% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $383,000 |
| Q3 2025 | — |
| Q2 2025 | $455,000 |
| Q1 2025 | — |
| Q4 2024 | — |
PEBO has spent almost nothing on buybacks in the past year.
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS's net debt is about 7.8 years of its operating earnings (EBITDA), down from 8.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MS.
PEBO Net Leverage
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
PEBO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 53.3 | Neutral |
| Stochastic | 47.2 | Neutral |
PEBO's weekly RSI is 53 (neutral) and its Stochastic is 47 (neutral).
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS is trading at 15x earnings, a 15% premium to the Financial Services sector's median of 13x.
PEBO PE vs Financial Services Sector
| Metric | PEBO | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 13x | 13% below |
| PE % | 59 | 63 | 4 pts below |
PEBO has the edge over MS on valuation relative to its sector.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS's trend is mixed: it's above three of its five weekly moving averages, and 46% above its 200-week average.
PEBO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $37.9 | 1.1% above |
| 20 week MA | $39.1 | 2.2% below |
| 50 week MA | $35.5 | 7.7% above |
| 100 week MA | $32.8 | 17% above |
| 200 week MA | $31.0 | 24% above |
PEBO has the edge over MS on trend strength, trading above more of its moving averages.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has finished higher in five of the last six years. It's up 4% so far in 2026.
PEBO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $34.7 | $27.0 | -22% |
| 2021 | $27.0 | $31.4 | +16% |
| 2022 | $31.4 | $28.5 | -9.1% |
| 2023 | $28.5 | $33.8 | +18% |
| 2024 | $33.8 | $31.9 | -5.5% |
| 2025 | $31.9 | $30.5 | -4.3% |
| 2026 YTD | $30.5 | $38.3 | +25% |
PEBO has the edge over MS on returns for 2026, with the stronger performance.